154 related articles for article (PubMed ID: 3505511)
1. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH; Balar DB; Patel TB
Indian J Cancer; 1987 Dec; 24(4):222-31. PubMed ID: 3505511
[No Abstract] [Full Text] [Related]
2. [Tumor markers in the upper intestinal tract--stomach and pancreas].
Pointner R; Conrad F; Schwab G
Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485
[TBL] [Abstract][Full Text] [Related]
3. [The value of preoperative diagnosis before second-look laparotomy in ovarian cancer].
Meden H; Rath W; Ohlmeyer D
Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):101-5. PubMed ID: 2180783
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
Lahousen M
Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA].
Vigné E; Krebs B; Khater R; Mira R; Boublil JL; Jourlait A; Frenay M; Namer M
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(5):609-13. PubMed ID: 3463621
[TBL] [Abstract][Full Text] [Related]
6. [Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?].
Sevelda P; Rosen A; Barrada M; Gober S; Vavra N; Salzer H
Gynakol Rundsch; 1990; 30 Suppl 1():210-1. PubMed ID: 2079273
[No Abstract] [Full Text] [Related]
7. [Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer].
Gadducci A; Ferdeghini M; Bartolini T; Facchini V; Bianchi R; Fioretti P
Ann Ostet Ginecol Med Perinat; 1986; 107(4):193-9. PubMed ID: 3467641
[No Abstract] [Full Text] [Related]
8. [Mucinous carcinoma-associated antigen (MCA) in ovarian cancer].
Hanzal E; Kölbl H; Gitsch G; Bieglmayer C
Gynakol Rundsch; 1990; 30 Suppl 1():68-70. PubMed ID: 2079303
[No Abstract] [Full Text] [Related]
9. [Clinical relevance of tumor markers for follow-up and therapy planning in ovarian cancer].
Böhm W; Lücke R; Ertle B; Benz R; Deinert S
Arch Gynecol Obstet; 1989; 245(1-4):640-2. PubMed ID: 2802749
[No Abstract] [Full Text] [Related]
10. [CA 15-3 in the diagnosis and monitoring of carcinoma of the breast and its correlations with CEA].
Festa V; Alabiso O; Piantino P; Lisa F; Zanini M; Garrone C; Simone P; Morino M
Minerva Chir; 1989 Mar; 44(6):1015-20. PubMed ID: 2733831
[TBL] [Abstract][Full Text] [Related]
11. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
[TBL] [Abstract][Full Text] [Related]
12. [Immunophenotypic characteristics of the epithelial cells of ovarian neoplasms].
Harłozińska-Szmyrka A
Postepy Hig Med Dosw; 1991; 45(1-2):45-62. PubMed ID: 1923996
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers for ovarian cancers].
Aoki D; Kataoka F; Susumu N; Nozawa S
Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
[No Abstract] [Full Text] [Related]
14. Clinical relevance of the CA-125 assay for the management of patients with ovarian carcinoma.
Raju RN; Dalbow MH; Pugh RP; Concannon JP; Zidar BL; Zamerilla CF; Schenken LL
Prog Clin Biol Res; 1987; 248():289-97. PubMed ID: 3478733
[No Abstract] [Full Text] [Related]
15. The significance of neopterin determination as a tumour marker in ovarian cancer.
Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
Sevelda P; Wagner G
Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
[TBL] [Abstract][Full Text] [Related]
17. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the T.A.T.I. marker with CEA and Ca 19-9 in neoplasms of the gastrointestinal system. Preliminary data].
Ricci E; Pecchio F; Rapellino M; Giaccone M; Adamo R; Boltri F; Oliaro A
Minerva Dietol Gastroenterol; 1988; 34(4):217-20. PubMed ID: 3247053
[No Abstract] [Full Text] [Related]
19. [Improving the diagnostic efficacy of carcinoembryonic antigen (CEA) in gastric cancer by the simultaneous administration of Ca 72.4].
Sagredo E; Soriano A; Vivanco FJ; Ruibal A
Rev Clin Esp; 1989 Apr; 184(6):336-7. PubMed ID: 2756226
[No Abstract] [Full Text] [Related]
20. [Blood serum galactosyltransferase in oncologic diseases].
Mikhaĭlov AD; Zhordaniia KI; Ivanov PK
Med Radiol (Mosk); 1989 Mar; 34(3):31-4. PubMed ID: 2494414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
